Newsroom

Industry News

4 May

Researchers Report that Thymosin B4 has a Major Role in Dermal Burn Wound Healing

RegeneRx Biopharmaceuticals, Inc. (RGRX)(“the Company” or “RegeneRx”) today announced that an independent team of researchers from South Korea have reported that Thymosin B4 (TB4) plays an important role in accelerating the repair of second-degree dermal burn wounds, induced in an experimental mouse model, by promoting blood vessel formation and...

Read more

4 May

Cesca Therapeutics Announces Changes in Management

Cesca Therapeutics Inc. (KOOL), an autologous cell-based regenerative medicine company, today announced that Mr. Dan T. Bessey has resigned as Chief Financial Officer of Cesca Therapeutics effective May 9, 2015. Mr. Bessey has accepted a position as Chief Financial Officer of Hawaiian Telcom, a provider of integrated communications services...

Read more

4 May

Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO

Soligenix, Inc. (SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that it will be presenting preclinical data from three of its biodefense programs at the upcoming Chemical and Biological Defense Science...

Read more

4 May

BioLineRx Initiates Expansion Stage of Phase 2 Clinical Trial for Novel Treatment for Acute Myeloid Leukemia

BL-8040 remains safe and well tolerated at highest dose; continues to induce robust mobilization and leukemia cell death. Top-line results expected Q4 2015 BioLineRx Ltd. (NASDAQ: BLRX; TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today successful completion of the dose escalation...

Read more

30 Apr

MOKO Expands Market to 4,000+ High Schools With BigTeams

Companies to Launch a Free Combined App, “BigTeams Powered by REC*IT” in the App Store and Google Play in Early Q3 MOKO Social Media Limited (NASDAQ: MOKO) (ASX: MKB), announced today that it has taken a 10 percent equity stake in BigTeams, the largest high school sports software platform...

Read more

30 Apr

Moko Social Media Chairman’s Quarterly Review March 2015

Moko Social Media Limited (NASDAQ: MOKO) (ASX: MKB) Highlights More than 8 million Monthly Unique Visitors across MOKO products as at March, up 60% from 5 million in December 2014 BigTeams deal extends REC*IT to highly lucrative high school student and parent demographics REC*IT 2.0 development progressing well with...

Read more

30 Apr

Inovio Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Inovio Pharmaceuticals, Inc. (INO) (“Inovio” or the “Company”), today announced the pricing of an underwritten public offering of 9,500,000 shares of common stock for a public offering price of $8.00 per share. The gross proceeds to Inovio from this offering are expected to be $76,000,000, before deducting the underwriting...

Read more

30 Apr

Evogene Files Annual Report for the Year Ended December 31, 2014

Evogene Ltd. (EVGN.TA) (EVGN.TA), a leading company for the improvement of crop quality, productivity and economics for the food, feed and biofuel industries, announced today that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2014 with the U.S. Securities and Exchange...

Read more

29 Apr

Inovio Pharmaceuticals Announces Public Offering of Common Stock

Inovio Pharmaceuticals, Inc. (INO) (“Inovio” or the “Company”), today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Piper Jaffray & Co. and Stifel are acting as joint bookrunning managers for the offering. The offering is subject to market conditions,...

Read more

Page 1 of 6612345...102030...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets